ROME (Reuters) – Italy’s health ministry on Tuesday recommended that the Johnson & Johnson COVID-19 vaccine be used for people over the age of 60, after Europe’s drugs regulator said the jab may be linked to blood clotting issues among younger people.
The ministry has already made the same recommendation for the use of the AstraZeneca vaccine in Italy.
(Reporting By Gavin Jones, editing by Valentina Za)
PGA Tour players learn how much loyalty is worth in new equity program
Ex-minor league umpire sues MLB, says he was harassed by female ump, fired for being bisexual man
Sixers in need of some home cooking in Game 3 against Knicks
LSU’s Jayden Daniels downplays issues with Commanders, says he’d be ‘blessed’ to go No. 2 overall
Lions agree to contract extensions with St. Brown and Sewell worth combined $200M, AP source says
To pass Ukraine aid, ‘Reagan Republican’ leaders in Congress navigated a party transformed by Trump
Columbia University protests: House Speaker Mike Johnson visits campus, calls for Shafik’s resignation amidst Pro-Palestine protest encampment
Another ex-State Department official alleges Israeli military gets ‘special treatment’ on abuses
Biden meets 4-year-old Abigail Edan, an American who was held hostage by Hamas
Hamas releases video showing well-known Israeli-American hostage
More cows are being tested and tracked for bird flu. Here’s what that means
More doctors can prescribe a leading addiction treatment. Why aren’t more people getting help?
Missouri House backs legal shield for weedkiller maker facing thousands of cancer-related lawsuits
Dairy cattle must be tested for bird flu before moving between states, agriculture officials say
